Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-193721
Filing Date
2020-07-16
Accepted
2020-07-16 07:56:29
Documents
2
Group Members
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.VIFOR PHARMA LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d28293dsc13da.htm SC 13D/A 129229
2 EX-99.12 d28293dex9912.htm EX-99.12 46533
  Complete submission text file 0001193125-20-193721.txt   177286
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Subject) CIK: 0001340652 (see all company filings)

EIN.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-86723 | Film No.: 201030768
SIC: 2834 Pharmaceutical Preparations

Mailing Address RECHENSTRASSE 37 ST. GALLEN V8 9000
Business Address RECHENSTRASSE 37 ST. GALLEN V8 9000 41 58 851 80 00
Vifor (International) Ltd (Filed by) CIK: 0001675217 (see all company filings)

EIN.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D/A